Summary
A secondary analysis of pooled data from the EINSTEIN-DVT and EINSTEIN-PE studies demonstrated the utility of 4 different bleeding risk scores to identify patients with deep vein thrombosis or pulmonary embolism who are at a low risk of bleeding. Patients aged < 65 years and without a history of bleeding or significant comorbidities had a rate of major bleeding of < 0.5% at 30 days.
- Deep vein thrombosis
- EINSTEIN-DVT study
- EINSTEIN-PE study
- major bleeding
- pulmonary embolism
- rivaroxaban
- venous thromboembolism
- VTE
- © 2015 SAGE Publications